Breaking News, Financial News

Financial Report: Allergan 3Q13

Revenues up 13% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Allergan 3Q Revenues: $1.6 billion (+13%) 3Q Earnings: $300.8 million (+20%) YTD Revenues: $4.6 billion (+11%) YTD Earnings: $676.4 million (-13%) Comments: Specialty pharmaceuticals sales were $1.3 billion in the quarter, up 13%. Eye Care Pharmaceuticals sales were $717.1 million, up 8%. Botox/Neuromodulators sales were $485.7 million, up 13%. Medical devices sales increased 13% to $198.6 million....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters